Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Effective decision-making: progressing compounds through clinical development.

Shillingford CA, Vose CW.

Drug Discov Today. 2001 Sep 15;6(18):941-946.

PMID:
11546608
2.

Disposition of [14C]velnacrine maleate in rats, dogs, and humans.

Turcan RG, Hillbeck D, Hartley TE, Gilbert PJ, Coe RA, Troke JA, Vose CW.

Drug Metab Dispos. 1993 Nov-Dec;21(6):1037-47.

PMID:
7905382
4.

Application of 19F-n.m.r. spectroscopy to the identification of dog urinary metabolites of imirestat, a spirohydantoin aldose reductase inhibitor.

Gilbert PJ, Hartley TE, Troke JA, Turcan RG, Vose CW, Watson KV.

Xenobiotica. 1992 Jul;22(7):775-87.

PMID:
1455900
5.

The Drug Metabolism Discussion Group 1991.

Franklin RA, Vose CW, Wiltshire H.

Xenobiotica. 1992 Jul;22(7):733-4. No abstract available.

PMID:
1455895
6.

Disposition of bemitradine, a renal vasodilator and diuretic, in man.

Walls CM, Gray A, Vose CW, Robinson Y, Lopez N, Brownsill RD, Steiner JA.

Xenobiotica. 1988 Dec;18(12):1413-23.

PMID:
3245233
7.

Single- and multiple-dose pharmacokinetics of nufenoxole in healthy human subjects.

Brownsill RD, Hiley MP, Vose CW, Steiner JA, Stafford JE, McAllister A, Rose DA, Gerry N.

Xenobiotica. 1987 Nov;17(11):1373-7.

PMID:
3433806
8.

Disposition of 3H-enisoprost, a gastric antisecretory prostaglandin, in healthy humans.

Allan LM, Hawkins AJ, Vose CW, Firth J, Brownsill RD, Steiner JA.

Xenobiotica. 1987 Oct;17(10):1233-46.

PMID:
3424870
9.

Studies on the disposition of a 5-nitroimidazole in laboratory animals.

Barrow A, Burford SR, Forrest TJ, Hawkins AJ, Rose DA, Stevens PM, Vose CW, Walls CM.

Eur J Drug Metab Pharmacokinet. 1987 Apr-Jun;12(2):85-90.

PMID:
3121339
10.
11.

Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridine.

Robinson Y, Gerry N, Brownsill RD, Vose CW.

Biomed Mass Spectrom. 1984 Apr;11(4):199-201.

PMID:
6733256
12.

Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-Banthine.

Rigby GV, Vose CW, Haskins NJ, Allan EF, Harrison IR, Shelton JR, Brownsill RD, Perkins RM, Ford GC, Hawkins AJ, et al.

Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):219-24.

PMID:
6689152
13.

Liquid chromatographic analysis of an antimicrobial 5-nitroimidazolyl-2-sulphide derivative in biological fluids.

Vose CW, Stevens PM, Dickens JP.

J Chromatogr. 1981 Oct 9;225(2):488-92. No abstract available.

PMID:
6795218
14.

The metabolism of canrenone in vitro by rat liver preparations.

Boreham DR, Vose CW, Palmer RF, Slater TF, Cheeseman K.

Xenobiotica. 1981 Apr;11(4):231-40.

PMID:
7303717
15.

Quantitation of metolazone in plasma and urine by high-performance liquid chromatography with fluorescence detection.

Vose CW, Muirhead DC, Evans GL, Stevens PM, Burford SR.

J Chromatogr. 1981 Feb 13;222(2):311-5. No abstract available.

PMID:
7251748
16.

Co-carcinogenicity of promoting agents.

Vose CW, Coombs MM, Bhatt TS.

Carcinogenesis. 1981;2(7):687-9.

PMID:
7273348
17.

Microsomal metabolites of the aryl hydrocarbon hydroxylase and tumour inhibitor 7,8-benzoflavone.

Coombs MM, Bhatt TS, Vose CW.

Carcinogenesis. 1981;2(2):135-40. No abstract available.

PMID:
7273297
18.

Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin.

Lewis CJ, Vose CW, Spalton PN, Ford GC, Haskins NJ, Palmer RF.

Xenobiotica. 1980 Sep;10(9):705-13.

PMID:
7445531
19.

Mutagenic and carcinogenic metabolites of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one.

Coombs MM, Bhatt TS, Kissonerghis AM, Vose CW.

Cancer Res. 1980 Mar;40(3):882-6.

20.

A fluorimetric assay for metolazone in urine.

Vose CW, Stevens PM, Muirhead DC, Palmer RF, McInnes GT.

Br J Clin Pharmacol. 1980 Feb;9(2):213-5. No abstract available.

21.

Plasma levels and urinary excretion of orally administered propantheline bromide in man.

Vose CW, Stevens PM, Haskins NJ, Waddell KA, Hawkins AJ, Rose DA, Evans GL, Palmer RF, Diaz V, Garza J, Martin O, Rudel H.

Eur J Drug Metab Pharmacokinet. 1980;5(1):29-34.

PMID:
7389749
22.

Identification of the proximate and ultimate forms of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one.

Coombs MM, Kissonerghis AM, Allen JA, Vose CW.

Cancer Res. 1979 Oct;39(10):4160-5. No abstract available.

23.

Identification of some human urinary metabolites of orally administered potassium canrenoate by stable isotope-labeling techniques.

Vose CW, Boreham DR, Ford GC, Haskins NJ, Palmer RF.

Drug Metab Dispos. 1979 Jul-Aug;7(4):226-32.

PMID:
39725
24.

Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate.

Vose CW, Butler JK, Williams BM, Stafford JE, Shelton JR, Rose DA, Palmer RF, Breckenridge AM, Orme ML, Serlin MJ.

Contraception. 1979 Feb;19(2):119-27.

PMID:
428229
25.

Pharmacokinetics of propantheline bromide in normal man.

Vose CW, Ford GC, Grigson SJ, Haskins NJ, Prout M, Stevens PM, Rose DA, Palmer RF, Rudel H.

Br J Clin Pharmacol. 1979 Jan;7(1):89-93. No abstract available.

26.

Identification of some urinary metabolites of propantheline bromide in man.

Vose CW, Prout M, Haskins NJ, Ford C, Palmer RF, Tidd MJ.

Xenobiotica. 1978 Dec;8(12):745-52.

PMID:
726518
27.

Electron impact and chemical ionization mass spectrometry of steroidal spirolactones.

Boreham DR, Ford GC, Haskins NJ, Vose CW, Palmer RF.

Biomed Mass Spectrom. 1978 Sep;5(9):524-30.

PMID:
708853
28.
29.

Urinary D-glucaric acid and oral contraceptives.

Stevens PM, Vose CW, Palmer RF.

Br J Clin Pharmacol. 1978 Jun;5(6):535-6. No abstract available.

30.
31.

The measurements of propantheline ion in biological fluids after administering propantheline bromide to man.

Ford GC, Grigson SJ, Haskins NJ, Palmer RF, Prout M, Vose CW.

Biomed Mass Spectrom. 1977 Apr;4(2):94-7.

PMID:
884212
32.

Radioimmunoassay of plasma norethisterone after ethynodiol diacetate administration.

Walls C, Vose CW, Horth CE, Palmer RF.

J Steroid Biochem. 1977 Feb;8(2):167-71. No abstract available.

PMID:
865120
33.
35.
36.

Supplemental Content

Support Center